TapImmune Inc. Enters into Definitive Agreements to Raise $6.82 Million in a Private Placement from Accredited Investors and from the Exercise of Warrants by Existing Institutional Investors

TapImmune has entered into definitive subscription agreements to raise aggregate gross proceeds of approximately $6.82 million in a private placement transaction with accredited investors and from the exercise of certain outstanding Series E warrants by certain existing institutional investors.

Details

Happy Nurses Week

In honor of National Nurses week, TapImmune would like to recognize and say thank you for all the hard work and dedication you put in every time you put those scrubs on! Being a nurse can be rewarding and difficult. Without you, patients would be left in the dark. Thank you for being the light for your patients. We especially would like to recognize Oncology Nurses.

Details

World Ovarian Cancer Day

Ovarian cancer is known as the most dangerous and serious gynecologic cancer. What’s even scarier is the women that are important in our lives are at risk of developing this disease. May 8, 2013, was the first World Ovarian Cancer Day. This day was created so that each year, individuals can raise awareness of this horrific disease that takes 140,000 women per year internationally.

Details